For example, looping between the c-MYC promoter and an enhancer that contains a cancer-associated SNP, rs6983267, was shown to occur equally in both alleles, and the phenotype is thought to be driven by an increase in enhancer activity due to differential transcription factor 4 (TCF4) binding [68]. Here, TCF4 is linked to cancer.